We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NNVC market cap is 22.95M. The company's latest EPS is USD -0.5781 and P/E is -2.61.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.03M | -2.18M | -1.91M | -2.39M | -3.17M |
| Net Income | -1.97M | -2.12M | -1.85M | -2.36M | -3.13M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8M | -8.74M | -8.11M | -8.94M | -8.52M |
| Net Income | -13.45M | -8.82M | -8.11M | -8.59M | -8.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.42M | 13.4M | 11.47M | 12.82M | 11.74M |
| Total Liabilities | 2.45M | 951k | 813k | 1.36M | 1.63M |
| Total Equity | 12.97M | 12.45M | 10.65M | 11.46M | 10.11M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.91M | 30.26M | 23.5M | 16.9M | 12.82M |
| Total Liabilities | 2.16M | 351k | 413k | 2.03M | 1.36M |
| Total Equity | 21.76M | 29.91M | 23.08M | 14.87M | 11.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.17M | -2.89M | -4.84M | -6.32M | -2.6M |
| Investing | -8k | -14k | -58k | -157k | -47k |
| Financing | N/A | N/A | N/A | 3.12M | 1.71M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.67M | -8.21M | -5.89M | -5.67M | -6.32M |
| Investing | -8k | -239k | -324k | -152k | -157k |
| Financing | 17.83M | 15.26M | -235k | -94k | 3.12M |
| Market Cap | 22.95M |
| Price to Earnings Ratio | -2.61 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.52 |
| Price to Book Ratio | 1.89 |
| Dividend Yield | - |
| Shares Outstanding | 14.35M |
| Average Volume (1 week) | 534.36k |
| Average Volume (1 Month) | 307.38k |
| 52 Week Change | 48.13% |
| 52 Week High | 3.59 |
| 52 Week Low | 1.0001 |
| Spread (Intraday) | 0.02 (1.25%) |
| Company Name | NanoViricides Inc |
| Address |
50 west liberty street reno, nevada 89501 |
| Website | https://www.nanoviricides.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
